Prevalence and comorbidities of double diabetes
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND A growing number of people with type 1 diabetes (T1DM) are identified with features of metabolic syndrome (MS) known as "double diabetes", but epidemiologic data on the prevalence of MS in T1DM and its comorbidities are still lacking. Aim of this cross sectional study is to better estimate the prevalence of MS in T1DM, and to assess its association with comorbidities. METHODS Data of 31,119 persons with autoimmune diabetes mellitus were analysed for signs of MS and presence of late complications. Double diabetes was defined as T1DM coexisting with MS (obesity, hypertension, dyslipidemia). Multiple linear or logistic regression analyses were performed to identify associations between double diabetes and late complications. RESULTS 25.5% (n=7926) of persons with T1DM presented additionally the MS. Persons with double diabetes showed significantly more macrovascular comorbidities (coronary heart disease 8.0% versus 3.0% w/o MS, stroke 3.6% versus 1.6%, diabetic foot syndrome 5.5% versus 2.1%). Also microvascular diseases were increased in people with double diabetes (retinopathy 32.4% versus 21.7%, nephropathy 28.3% versus 17.8%). Both macrovascular and microvascular comorbidities were increased independent of glucose control, even if patients with good metabolic control (HbA1c <7.0%, 53mmol/mol) showed significantly less macrovascular (coronary heart disease 2.3% versus 1.8%, p<0.0001) and microvascular problems (retinopathy 8.7% versus 6.6%, p<0.0001). CONCLUSIONS Double diabetes seems to be an independent and important risk factor for persons with T1DM in developing macrovascular and microvascular comorbidities. Therefore, patients should be identified and development of MS should be avoided. Longterm studies are needed to observe the effect of insulin resistance on patients with autoimmune diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 4×
“Aim of the following study is to analyse the prevalence of MS - defined according to the NCEP (National Cholesterol Education Program) criteria as obesity, dyslipidaemia and arterial hypertension combined with insulin resistance - in people with T1DM [10].”
InfluentialLachin, J. M., Orchard, T. J., Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2116 · Cited by 206 · cited 3×
“These data suggest that double diabetes entails a higher risk for any type of macrovascular comorbidities resulting in a higher prevalence of such events compared to data of UKPDS, EDC, EDIC or EURODIAB [28,31,32].”
Type 1 diabetes, metabolic syndrome and cardiovascular risk
Chillarón, J. J., Flores Le-Roux, J. A., Benaiges, D., & Pedro-Botet, J. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.002 · Cited by 195
Cited by
The Role of Inflammation in Diabetic Retinopathy
Forrester, J. V., Kuffova, L., & Delibegovic, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583687 · Cited by 432
Double diabetes: a distinct high-risk group?
Kietsiriroje, N., Pearson, S., Campbell, M., Ariëns, R. A. S., & Ajjan, R. A. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13848 · Cited by 123
Hansen, A. H., Bradway, M., Broz, J., Claudi, T., Henriksen, Ø., Wangberg, S. C., & Årsand, E. (2019) · Journal of Medical Internet Research · doi:10.2196/13615 · Cited by 38
“A total of 5 of these were overlapping, interpreted as double diabetes [37,38].”
BackgroundGajewska, K. A., Biesma, R., Sreenan, S., & Bennett, K. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032916 · Cited by 15
Metadata
- Authors
- Merger, S. R., Kerner, W., Stadler, M., Zeyfang, A., Jehle, P., Müller-Korbsch, M., & Holl, R. W.
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 119
- Pages
- 48-56
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2468934871
- Cited by
- 128
- References
- 3
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and comorbidities of double diabetes. https://app.cochat.ai/papers/10.1016/j.diabres.2016.06.003
- The paper
- Merger, S. R., Kerner, W., Stadler, M., Zeyfang, A., Jehle, P., Müller-Korbsch, M., & Holl, R. W. (2016). Prevalence and comorbidities of double diabetes. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2016.06.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.